Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopenia

Annals of Surgical Oncology

Volumn 16, Issue 7, 2009, Pages 2014-2017

  Gumbs, Andrew A ^a   Zain, Jasmine ^b   O'Connor, Owen A ^b  

^a FOX CHASE CANCER CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE; GAMMA INTERFERON; GEMCITABINE; INFLIXIMAB; MERCAPTOPURINE; PENTOSTATIN; PRALATREXATE; STEROID;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; ARTICLE; B CELL LYMPHOMA; BLEEDING; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; GASTROINTESTINAL HEMORRHAGE; HEPATOSPLENIC T CELL LYMPHOMA; HEPATOSPLENOMEGALY; HUMAN; LAPAROSCOPIC SURGERY; LETHALITY; LYMPHADENOPATHY; MALE; MULTIPLE CYCLE TREATMENT; PANCYTOPENIA; PHYSICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PROGNOSIS; SPLENECTOMY; SPLENIC LYMPHOMA; STANDARDIZED UPTAKE VALUE; SURVIVAL RATE; SYMPTOM; T CELL LYMPHOMA; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; WEIGHT REDUCTION;

AMINOPTERIN; FATAL OUTCOME; HEMATOLOGIC AGENTS; HUMANS; LAPAROSCOPY; LIVER NEOPLASMS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; SPLENECTOMY; SPLENIC NEOPLASMS; THROMBOCYTOPENIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649197400     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0470-0     Document Type: Article

References (14)

1. O'Connor OA. Pralatrexate: an emerging new agent with activity in T-cell lymphomas Curr Opin Oncol. 2006;18(6):591-7.
2. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990 Leukemia. 2000;14(6):991-7.
3. Moleti ML, Testi AM, Giona F, et al. Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up successfully treated with chemotherapy alone Leuk Lymphoma. 2006;47(2):333-6.
4. Sallah S, Smith SV, Lony LC, Woodard P, Schmitz JL, Folds JD. Gamma/delta T-cell hepatosplenic lymphoma: review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia Ann Hematol. 1997;74(3):139-42.
5. Veres G, Baldassano RN, Mamula P. Infliximab therapy for pediatric Crohn's disease Expert Opin Biol Ther. Dec 2007;7(12): 1869-80.
6. Veres G, Baldassano RN, Mamula P. Infliximab therapy in children and adolescents with inflammatory bowel disease Drugs. 2007;67(12):1703-23.
7. O'Connor OA, Hamlin P. New drugs for the treatment of advanced-stage diffuse large cell lymphomas Semin Hematol. Oct 2006;43(4):251-61.
8. O'Connor OA, Hamlin PA, Portlock C, et al. Pralatrexate, a novel class of antifol with high affinity for the reduced folate carriertype 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma Br J Haematol. 2007;139(3):425-8.
9. Rosh JR, Gross T, Mamula P, Griffiths A, Hyams J. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis. Aug 2007;13(8):1024-30.
10. Mackey AC, Green L, Liang LC, Dinndorf P, Avigan M. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease J Pediatr Gastroenterol Nutr. Feb 2007;44(2):265-7.
11. Isaacson PG. Primary splenic lymphoma Cancer Surv. 1997;30: 193-212.
12. Chen JH, Chan DC, Lee HS, et al. Spontaneous splenic rupture associated with hepatosplenic gammadelta T-cell lymphoma J Formos Med Assoc. 2005;104(8):593-6.
13. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta Blood. Jun 1 1990;75 (11):2213-9.
14. Gumbs AA, Bouhanna P, Bar-Zakai B, Briennon X, Gayet B. Laparoscopic partial splenectomy using radiofrequency ablation. J Laparoendosc Adv Surg Tech. 2008;18(4):611-3.